Hepatitis B reactivation in patients receiving direct-acting antiviral therapy or interferon-based therapy for hepatitis C: A systematic review and meta-analysis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hepatitis B reactivation in patients receiving direct-acting antiviral therapy or interferon-based therapy for hepatitis C: A systematic review and meta-analysis
Authors
Keywords
-
Journal
WORLD JOURNAL OF GASTROENTEROLOGY
Volume 24, Issue 28, Pages 3181-3191
Publisher
Baishideng Publishing Group Inc.
Online
2018-07-27
DOI
10.3748/wjg.v24.i28.3181
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy of Ledipasvir and Sofosbuvir Treatment of HCV Infection in Patients Coinfected With HBV
- (2018) Chun-Jen Liu et al. GASTROENTEROLOGY
- Hepatitis B reactivation in chronic hepatitis C patients treated with interferon or pan-oral direct-acting antivirals
- (2017) Jiaye Liu HEPATOLOGY
- Hepatitis B reactivation in hepatitis B and C coinfected patients treated with antiviral agents: A systematic review and meta-analysis
- (2017) Guofeng Chen et al. HEPATOLOGY
- Evaluation of hepatitis B reactivation among 62,920 veterans treated with oral hepatitis C antivirals
- (2017) Pamela S. Belperio et al. HEPATOLOGY
- Frequency of, and factors associated with, hepatitis B virus reactivation in hepatitis C patients treated with all-oral direct-acting antivirals: Analysis of a Japanese prospective cohort
- (2017) Akira Doi et al. HEPATOLOGY RESEARCH
- Hepatitis B virus reactivation among hepatitis C patients treated with direct-acting antiviral therapies in routine clinical practice
- (2017) Elisabetta Loggi et al. JOURNAL OF CLINICAL VIROLOGY
- Reactivation of hepatitis B in patients of chronic hepatitis C with hepatitis B virus infection treated with direct acting antivirals
- (2017) Ming-Lun Yeh et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Outcome of patients with compensated liver cirrhosis with hepatitis B virus + hepatitis C virus coinfection treated with paritaprevir/ombitasvir/ritonavir, dasabuvir with ribavirin: a national cohort study
- (2017) C. Preda et al. JOURNAL OF HEPATOLOGY
- Absence of hepatitis B reactivation among veterans with serological evidence of previous hepatitis B infection receiving anti-hepatitis C direct acting antivirals
- (2017) L. Tang et al. JOURNAL OF HEPATOLOGY
- EASL Recommendations on Treatment of Hepatitis C 2016
- (2017) JOURNAL OF HEPATOLOGY
- Managing sharps injuries and other occupational exposures to HIV, HBV, and HCV in the dermatology office
- (2017) Jerry D. Brewer et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Low incidence of hepatitis B virus reactivation and subsequent hepatitis in patients with chronic hepatitis C receiving direct-acting antiviral therapy
- (2017) A. Tamori et al. JOURNAL OF VIRAL HEPATITIS
- Comparing the risk of hepatitis B virus reactivation between direct-acting antiviral therapies and interferon-based therapies for hepatitis C
- (2017) N. Kawagishi et al. JOURNAL OF VIRAL HEPATITIS
- HBV reactivation in patients with HCV/HBV cirrhosis on treatment with direct-acting antivirals
- (2017) V. Calvaruso et al. JOURNAL OF VIRAL HEPATITIS
- Potential risk of HBV reactivation in patients with resolved HBV infection undergoing direct-acting antiviral treatment for HCV
- (2017) Eiichi Ogawa et al. LIVER INTERNATIONAL
- Ledipasvir and sofosbuvir for HCV-infection in patients coinfected with HBV
- (2016) Edward J Gane et al. ANTIVIRAL THERAPY
- No Evidence of Reactivation of Hepatitis B Virus Among Patients Treated With Ledipasvir-Sofosbuvir for Hepatitis C Virus Infection: Table 1.
- (2016) Mark S. Sulkowski et al. CLINICAL INFECTIOUS DISEASES
- The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013
- (2016) Jeffrey D Stanaway et al. LANCET
- Recent US Food and Drug Administration warnings on hepatitis B reactivation with immune-suppressing and anticancer drugs: Just the tip of the iceberg?
- (2015) Adrian M. Di Bisceglie et al. HEPATOLOGY
- Personalized Therapy of Chronic Hepatitis C and B Dually Infected Patients With Pegylated Interferon Plus Ribavirin
- (2015) Ming-Lun Yeh et al. MEDICINE
- The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
- (2013) Alessandro Liberati ANNALS OF INTERNAL MEDICINE
- Management of patients with hepatitis B who require immunosuppressive therapy
- (2013) Jessica P. Hwang et al. Nature Reviews Gastroenterology & Hepatology
- Sustained HCV clearance by interferon-based therapy reduces hepatocellular carcinoma in hepatitis B and C dually-infected patients
- (2011) Chao-Hung Hung et al. ANTIVIRAL THERAPY
- Dual chronic hepatitis B virus and hepatitis C virus infection
- (2009) Chun-Jen Liu et al. Hepatology International
- Hepatitis B virus and hepatitis C virus interaction in Huh-7 cells
- (2009) Nicholas S. Eyre et al. JOURNAL OF HEPATOLOGY
- Analysis of the efficacy of treatment with peginterferon α-2a and ribavirin in patients coinfected with hepatitis B virus and hepatitis C virus
- (2009) Jian-Wu Yu et al. LIVER INTERNATIONAL
- Peginterferon Alfa-2a Plus Ribavirin for the Treatment of Dual Chronic Infection With Hepatitis B and C Viruses
- (2008) Chun–Jen Liu et al. GASTROENTEROLOGY
- The HEP-NET B/C co-infection trial: A prospective multicenter study to investigate the efficacy of pegylated interferon-α2b and ribavirin in patients with HBV/HCV co-infection
- (2008) Andrej Potthoff et al. JOURNAL OF HEPATOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started